Jan 4 (Reuters) - Portage Biotech Inc PRTG.O :
* PORTAGE BIOTECH REPORTS BUSINESS AND STRATEGIC UPDATE
* SAYS CO WILL EVALUATE RANGE OF STRATEGIC OPTIONS
* IMPLEMENTING A COST-SAVINGS PLAN THAT INCLUDES A REDUCTION
IN
INTERNAL AND CONTRACTED WORKFORCE
* INKT CLINICAL DEVELOPMENT PAUSED TO FOCUS RESOURCES
* PRIORITIZE ADENOSINE CLINICAL CANDIDATES
* REMAINING EMPLOYEES TO FOCUS PRIMARILY ON PURSUING
ADENOSINE
CLINICAL PROGRAMS
Source text for Eikon: ID:nGNXDzBKw
Further company coverage: PRTG.O
((Reuters.Briefs@thomsonreuters.com;))